S'abonner

The role of the quick sequential organ failure assessment score (qSOFA) and modified early warning score (MEWS) in the pre-hospitalization prediction of sepsis prognosis - 24/02/21

Doi : 10.1016/j.ajem.2020.09.049 
Eren Usul, MD a, , Semih Korkut, MD b, Afsin Emre Kayipmaz, MD c, Ali Halici, MD d, Cemil Kavalci, MD e
a Sincan Dr Nafiz Körez State Hospital, Department of Emergency, Ankara, Turkey 
b University of Health Sciences, Kartal Dr Lütfi Kırdar Training and Research Hospital, Department of Emergency, Istanbul, Turkey 
c Ankara City Hospital, Department of Emergency, Ankara, Turkey 
d Polatlı Duatepe State Hospital, Department of Emergency, Ankara, Turkey 
e University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Department of Emergency, Ankara, Turkey 

Corresponding author at: Tevfik İleri Mahallesi, Yıldırım Bulvarı, Leman Sokak, Sarp Sitesi 6/34, Pursaklar, Ankara, Turkey.Tevfik İleri MahallesiYıldırım BulvarıLeman SokakSarp Sitesi 6/34PursaklarAnkaraTurkey

Abstract

Objective

Many biomarkers and scoring systems to make clinical predictions about the prognosis of sepsis have been investigated. In this study, we aimed to assess the use of the quick sequential organ failure assessment score (qSOFA) and modified early warning score (MEWS) scoring systems in emergency health care services for sepsis to predict intensive care hospitalization and 28-day mortality.

Method

Patients who arrived by ambulance at the Emergency Department (ED) of Dışkapı YıldırımBeyazıt Training and Research Hospital between January 2017 and December 2019, and who were diagnosed with sepsis and admitted to the hospital were included in the study. Demographic data and physiological parameters from 112 ambulance case delivery forms were recorded.QSOFA and MEWS scores were calculated from vital parameters.

Results

Of the 266 patients diagnosed with sepsis, 50% (n = 133) were female, and the mean age was 74.8 ± 13. The difference between the rate of intensive care (ICU) hospitalization and mortality for patients with a high MEWS and qSOFA score and patients whose MEWS and qSOFA score were lower was found to be statistically significant (p < 0.05). Thus, the criteria for MEWS and qSOFA could determine ICU hospitalization and early mortality. Those with a high MEWS value had a mortality rate approximately 1.24 times higher than those with a low MEWS value (p < 0.001, 95% CI: 1.110–1.385), while those with a high qSOFA score had a mortality rate approximately 2.0 times higher than those with a low qSOFA score (p < 0.001, 95% CI: 1.446–2.693). Those with a high MEWS were 1.34 times more likely than hose with a lower MEWS to require ICU hospitalization (p < 0.001, 95% CI: 1.1773–1.5131), while patients with a high qSOFA score were 3.21 times more likely than those with a lower qSOFA score to require ICU care (p < 0.001, 95% CI: 2.2289–4.6093).

Conclusion

Although qSOFA and MEWS are clinical scores used to identify septic patients outside the critical care unit, we believe that patients already diagnosed with sepsis can be assessed with qSOFA and MEWS prior to hospitalization to predict intensive care hospitalization and mortality. qSOFA was found be more valuable than MEWS in determining the prognosis of pre-hospitalization sepsis.

Le texte complet de cet article est disponible en PDF.

Keywords : Prehospital, Sepsis, qSOFA, MEWS, Prognosis


Plan


© 2020  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 41

P. 158-162 - mars 2021 Retour au numéro
Article précédent Article précédent
  • Predictive performance of blood urea nitrogen to serum albumin ratio in elderly patients with gastrointestinal bleeding
  • Sung Jin Bae, Keon Kim, Seong Jong Yun, Sun Hwa Lee
| Article suivant Article suivant
  • Comparison of manual and mechanical chest compression techniques using cerebral oximetry in witnessed cardiac arrests at the emergency department: A prospective, randomized clinical study
  • Filiz Baloglu Kaya, Nurdan Acar, Engin Ozakin, Mustafa Emin Canakci, Caglar Kuas, Muzaffer Bilgin

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.